Table 2.

Comparison of curative effects in the two groups.

Group	Group A	Group B	P
Number of included patients	53	54
Serum potassium level at baseline, mmol/L	5.57 ± 0.26	5.58 ± 0.27	0.801
Number of patients who completed 3 days of treatment	50	51
Decrease of serum potassium levels, mmol/L	0.68 ± 0.46	0.75 ± 0.43	0.320
Number of patients with standard serum potassium (%)	30 (60%)	36 (70.6%)	0.300
Number of patients who do not achieve standard serum potassium levels (%)	20 (40%)	15 (29.4%)	0.300
Number of patients with increased serum potassium levels versus baseline (%)	4 (8%)	1 (2%)
Number of patients who completed 7 days of treatment	47	49
Decrease of serum potassium levels, mmol/L	0.64 ± 0.37	0.94 ± 0.49	0.001
Number of patients with standard serum potassium levels (%)	27 (57.4%)	38 (77.6%)	0.049